Challenges
Innovation under intense scrutiny
In life sciences, discovery is only half the battle. Regulatory approval processes are complex and lengthy. Public scepticism towards pharma and biotech is rising. Competition for funding is fierce, with investors demanding clear differentiation. And every breakthrough must be communicated with both scientific rigour and human relevance.
- Regulatory complexity
- Public scepticism
- Fierce competition for funding
- Translating science into human stories
